$10.29
-0.01 (-0.10%)
WENN News7 articles
Wendy's Shares Surge on Retail Frenzy, Short Squeeze Potential
Wendy's shares jumped 7.1% to $8.42, propelled by retail investors and social media buzz, even as Q1 same-store sales fell 7.8% and net income dropped 42.1%.
Wendy's Stock Surges on Record Volume Amid Short Squeeze and CFO Change
Wendy's stock surged 25.8% on record volume, with short interest at 34% and a new CFO appointed, adding pressure to its turnaround plans.
Wendy's New CFO Takes Helm Amidst High Dividend Yield and Short Seller Scrutiny
Wendy's stock closed up 1.38% at $6.255, with a nearly 9% dividend yield and short interest at 29.67% of float, as new CFO Steve Cirulis focuses on financial discipline amid weak U.S. traffic.
Wendy's New CEO Faces Uphill Battle as Sales Slide Continues
Wendy's same-store sales fell 7.8% in Q1, following an 11.3% Q4 decline. New CEO Robert Wright takes over as the chain closes 164 U.S. locations and faces activist investor pressure.
FBI Probes Crypto Investor Wen Hou's Father Disappearance Amid Fraud Allegations
FBI probes disappearance of Naiping Hou, father of crypto investor Wen Hou, amid cellphone spoofing and fraudulent bank transactions. Soybeans steady despite export sales drop.
BioCryst Shares Slip on New HAE Drug Data, Focus Shifts to Cowen Conference
BioCryst Pharmaceuticals shares fell premarket following new clinical data for its hereditary angioedema candidate navenibart. The company maintained its 2026 revenue outlook for ORLADEYO and targets a late-2027 regulatory submission.
BioCryst Shares Slide on HAE Drug Data, Focus Shifts to Cowen Conference
BioCryst Pharmaceuticals shares fell nearly 3% in premarket trading following new clinical data for its hereditary angioedema candidate navenibart. The company maintained its 2026 revenue outlook for ORLADEYO.